1. Home
  2. ONL vs CNTB Comparison

ONL vs CNTB Comparison

Compare ONL & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.62

Market Cap

165.4M

Sector

Real Estate

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.13

Market Cap

135.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
CNTB
Founded
2021
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.4M
135.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ONL
CNTB
Price
$2.62
$2.13
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.00
$8.67
AVG Volume (30 Days)
187.4K
487.0K
Earning Date
05-07-2026
08-13-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,647,000.00
$64,000.00
Revenue This Year
$4.10
N/A
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$1.23
52 Week High
$3.04
$3.82

Technical Indicators

Market Signals
Indicator
ONL
CNTB
Relative Strength Index (RSI) 43.63 40.68
Support Level $2.62 $2.03
Resistance Level $2.71 $2.75
Average True Range (ATR) 0.07 0.18
MACD -0.00 -0.03
Stochastic Oscillator 36.36 4.88

Price Performance

Historical Comparison
ONL
CNTB

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: